Literature DB >> 31578206

Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.

Shannon Kozlovich1, Gang Chen1, Christy J W Watson1, William J Blot1, Philip Lazarus2.   

Abstract

Menthol, which creates mint flavor and scent, is often added to tobacco in both menthol and nonmenthol cigarettes. A potent tobacco carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), is extensively metabolized to its equally carcinogenic metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) as (R)- or (S)-NNAL enantiomers. NNAL is detoxified by UDP-glucuronosyltransferase (UGT) enzymes, with glucuronidation occurring on either NNAL's pyridine ring nitrogen (NNAL-N-Gluc) or the chiral alcohol [(R)- or (S)-NNAL-O-Gluc]. To characterize a potential effect by menthol on NNAL glucuronidation, in vitro menthol glucuronidation assays and menthol inhibition of NNAL-Gluc formation assays were performed. Additionally, NNAL and menthol glucuronides (MG) were measured in the urine of smokers (n = 100) from the Southern Community Cohort Study. UGTs 1A9, 1A10, 2A1, 2A2, 2A3, 2B4, 2B7, and 2B17 all exhibited glucuronidating activity against both l- and d-menthol. In human liver microsomes, both l- and d-menthol inhibited the formation of each NNAL-Gluc, with a stereospecific difference observed between the formation of (R)-NNAL-O-Gluc and (S)-NNAL-O-Gluc in the presence of d-menthol but not l-menthol. With the exception of three nonmenthol cigarette smokers, urinary MG was detected in all menthol and nonmenthol smokers, with l-MG comprising >98% of total urinary MG. Levels of urinary NNAL-N-Gluc were significantly (P < 0.05) lower among subjects with high levels of total urinary MG; no significant changes in free NNAL were observed. These data suggest that the presence of menthol could lead to increases in alternative, activating metabolic pathways of NNAL in tobacco target tissues, increasing the opportunity for NNAL to damage DNA and lead to the development of tobacco-related cancers. SIGNIFICANCE STATEMENT: High levels of the major menthol metabolite, menthol-glucuronide, was observed in the urine of smokers of either menthol or nonmenthol cigarettes. The fact that a significant inverse correlation was observed between the levels of urinary menthol-glucuronide and NNAL-N-glucuronide, a major detoxification metabolite of the tobacco carcinogen, NNK, suggests that menthol may inhibit clearance of this important tobacco carcinogen.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31578206      PMCID: PMC7031765          DOI: 10.1124/dmd.119.088351

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  64 in total

1.  The Southern Community Cohort Study: investigating health disparities.

Authors:  Lisa B Signorello; Margaret K Hargreaves; William J Blot
Journal:  J Health Care Poor Underserved       Date:  2010-02

2.  Characterization of measured menthol in 48 U.S. cigarette sub-brands.

Authors:  Carolyn C Celebucki; Geoffrey Ferris Wayne; Gregory N Connolly; James F Pankow; Elsa I Chang
Journal:  Nicotine Tob Res       Date:  2005-08       Impact factor: 4.244

3.  Disposition kinetics and effects of menthol.

Authors:  A Gelal; P Jacob; L Yu; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  1999-08       Impact factor: 6.875

4.  Menthol Content in US Marketed Cigarettes.

Authors:  Jiu Ai; Kenneth M Taylor; Joseph G Lisko; Hang Tran; Clifford H Watson; Matthew R Holman
Journal:  Nicotine Tob Res       Date:  2015-08-09       Impact factor: 4.244

5.  Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform.

Authors:  Ryan W Dellinger; Jia-Long Fang; Gang Chen; Rebecca Weinberg; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2006-03-01       Impact factor: 3.922

6.  Menthol cigarettes and health risks in Lung Health Study data.

Authors:  Robert P Murray; John E Connett; Melissa A Skeans; Donald P Tashkin
Journal:  Nicotine Tob Res       Date:  2007-01       Impact factor: 4.244

7.  Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines.

Authors:  Gang Chen; Ryan W Dellinger; Carla J Gallagher; Dongxiao Sun; Philip Lazarus
Journal:  Pharmacogenet Genomics       Date:  2008-03       Impact factor: 2.089

8.  Nicotine metabolism and intake in black and white smokers.

Authors:  E J Pérez-Stable; B Herrera; P Jacob; N L Benowitz
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

9.  Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  R S Caraballo; G A Giovino; T F Pechacek; P D Mowery; P A Richter; W J Strauss; D J Sharp; M P Eriksen; J L Pirkle; K R Maurer
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

10.  Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.

Authors:  Dongxiao Sun; Gang Chen; Ryan W Dellinger; Kimberly Duncan; Jia-Long Fang; Philip Lazarus
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

View more
  2 in total

1.  Alkylating and oxidative stresses in smoking and non-smoking patients with COPD: Implications for lung carcinogenesis.

Authors:  Ying-Ming Shih; Yuan-Jhe Chang; Marcus S Cooke; Chih-Hong Pan; Ching-Hsuan Hu; Mu-Rong Chao; Chiung-Wen Hu
Journal:  Free Radic Biol Med       Date:  2021-01-05       Impact factor: 7.376

Review 2.  Mentha: Nutritional and Health Attributes to Treat Various Ailments Including Cardiovascular Diseases.

Authors:  Saddam Saqib; Fazal Ullah; Muhammad Naeem; Muhammad Younas; Asma Ayaz; Sajid Ali; Wajid Zaman
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.